Stock Events

Stock Events

Quest Diagnostics 

€162.95
241
-€0.9-0.55% Tuesday 19:55

Statistics

Day High
163.85
Day Low
162
52W High
179.45
52W Low
141.6
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
1.83%
Dividend
2.98

Upcoming

7
JUL
Dividend Ex
Estimated
 
21
JUL
Dividend Payment
Estimated
 
5
OCT
Dividend Ex
Estimated
 
20
OCT
Dividend Payment
Estimated
 
13
JAN 27
Dividend Ex
Estimated
 

Dividends

1.83%Dividend Yield
Apr 26
€0.75
Jan 26
€0.69
Oct 25
€0.68
Jul 25
€0.68
Apr 25
€0.73
10Y Growth
7.53%
5Y Growth
7.44%
3Y Growth
4.24%
1Y Growth
3.52%

Earnings

28JulExpected
Q4 2025
Q1 2026
Next
1.99
2.13
2.27
2.41
Expected EPS
2.4123099418200002
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QDI.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Labcorp
LH
Mkt Cap21.06B
Laboratory Corporation of America Holdings operates as a direct competitor, offering similar clinical laboratory and end-to-end drug development services.
Bio-Rad Laboratories
BIO
Mkt Cap6.93B
Bio-Rad Laboratories, Inc. provides a range of products and systems used to separate complex chemical and biological materials, directly competing in the diagnostics and research market.
Thermo Fisher Scientific
TMO
Mkt Cap174.37B
Thermo Fisher Scientific Inc. offers similar diagnostic test products and services, competing in the life sciences and healthcare sectors.
Danaher
DHR
Mkt Cap123.97B
Danaher Corporation operates in the diagnostics and research sector, offering products and services that compete with Quest Diagnostics in the healthcare diagnostics field.
Agilent Technologies
A
Mkt Cap32.36B
Agilent Technologies, Inc. provides instruments, services, consumables, applications, and expertise, competing in the life sciences and diagnostics sectors.
Guardant Health
GH
Mkt Cap11.61B
Guardant Health, Inc. specializes in liquid biopsy tests, which are part of the growing diagnostics market, competing with Quest Diagnostics in cancer diagnostics.
Neogenomics
NEO
Mkt Cap1.17B
NeoGenomics, Inc. specializes in cancer diagnostics and pharma services, directly competing with Quest Diagnostics in the oncology diagnostics market.
Myriad Genetics
MYGN
Mkt Cap466.55M
Myriad Genetics, Inc. focuses on molecular diagnostic tests, competing in the personalized medicine and genetic testing market.

About

There is no Profile data available for QDI.SG.
Show more...
CEO
Country
United States
ISIN
US74834L1008

Listings

F
DE
QDI.F
MI
IT
1QDX.MI
STU
DE
QDI.STU
LSE
GB
0KSX.LSE

0 Comments

Share your thoughts

FAQ

What is Quest Diagnostics stock price today?▼
The current price of QDI.STU is €162.95 EUR — it has decreased by -0.55% in the past 24 hours. Watch Quest Diagnostics stock price performance more closely on the chart.
What is Quest Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quest Diagnostics stocks are traded under the ticker QDI.STU.
Is Quest Diagnostics stock price growing?▼
QDI.STU stock has risen by +0.4% compared to the previous week, the month change is a -4.99% fall, over the last year Quest Diagnostics has showed a +5.23% increase.
When is the next Quest Diagnostics earnings date?▼
Quest Diagnostics is going to release the next earnings report on July 28, 2026.
What were Quest Diagnostics earnings last quarter?▼
QDI.STU earnings for the last quarter are 2.13 EUR per share, whereas the estimation was 2.01 EUR resulting in a +5.67% surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Quest Diagnostics pay dividends?▼
Yes, QDI.STU dividends are paid quarterly. The last dividend per share was 0.75 EUR. As of today, Dividend Yield (FWD)% is 1.83%.
In which sector is Quest Diagnostics located?▼
Quest Diagnostics operates in the Materials sector.
When did Quest Diagnostics complete a stock split?▼
Quest Diagnostics has not had any recent stock splits.